|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 55.86 USD | -0.04% |
|
+2.82% | +16.72% |
| 01/12 | JPMorgan Downgrades MPLX to Neutral From Overweight, Price Target is $57 | MT |
| 24/11 | Sector Update: Energy Stocks Advance Premarket Monday | MT |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 5.45 | 6.45 | 7.79 | 7.45 | 7.57 | |||||
Return on Total Capital | 5.77 | 6.81 | 8.23 | 7.87 | 8.02 | |||||
Return On Equity % | -4.35 | 23.05 | 29.99 | 29.27 | 31.58 | |||||
Return on Common Equity | -6.03 | 25.14 | 33.11 | 31.53 | 32.89 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 61.48 | 56.39 | 54.91 | 56.39 | 56.84 | |||||
SG&A Margin | 4.44 | 3.64 | 3.01 | 3.55 | 3.84 | |||||
EBITDA Margin % | 55.57 | 51.51 | 50.87 | 51.62 | 51.83 | |||||
EBITA Margin % | 40.95 | 39.57 | 40.95 | 41.46 | 41.51 | |||||
EBIT Margin % | 39.38 | 38.25 | 39.82 | 40.26 | 40.3 | |||||
Income From Continuing Operations Margin % | -8.08 | 32.06 | 35.72 | 37.13 | 39.14 | |||||
Net Income Margin % | -8.47 | 31.7 | 35.41 | 36.78 | 38.78 | |||||
Net Avail. For Common Margin % | -9.9 | 30.25 | 34.04 | 35.65 | 38.46 | |||||
Normalized Net Income Margin | 10.95 | 20.1 | 22.06 | 22.92 | 24.16 | |||||
Levered Free Cash Flow Margin | 12.13 | 28.32 | 23.28 | 22.86 | 22.91 | |||||
Unlevered Free Cash Flow Margin | 17.54 | 32.71 | 27.38 | 27.6 | 27.72 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.22 | 0.27 | 0.31 | 0.3 | 0.3 | |||||
Fixed Assets Turnover | 0.38 | 0.46 | 0.56 | 0.55 | 0.56 | |||||
Receivables Turnover (Average Receivables) | 6.89 | 7.83 | 7.54 | 6.86 | 7.02 | |||||
Inventory Turnover (Average Inventory) | 28.74 | 32.56 | 34.63 | 30.35 | 28.34 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 0.73 | 0.45 | 0.79 | 1.07 | 1.01 | |||||
Quick Ratio | 0.57 | 0.4 | 0.72 | 0.99 | 0.95 | |||||
Operating Cash Flow to Current Liabilities | 2.17 | 1.47 | 2.09 | 2.06 | 1.84 | |||||
Days Sales Outstanding (Average Receivables) | 53.13 | 46.62 | 48.39 | 53.19 | 52.13 | |||||
Days Outstanding Inventory (Average Inventory) | 12.74 | 11.21 | 10.54 | 12.03 | 12.91 | |||||
Average Days Payable Outstanding | 89.16 | 35.75 | 33.03 | 35.84 | 32.84 | |||||
Cash Conversion Cycle (Average Days) | -23.29 | 22.08 | 25.9 | 29.37 | 32.2 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 147.86 | 157.59 | 150.22 | 153.96 | 153 | |||||
Total Debt / Total Capital | 59.65 | 61.18 | 60.04 | 60.62 | 60.48 | |||||
LT Debt/Equity | 141.92 | 142.16 | 142.56 | 145.27 | 140.59 | |||||
Long-Term Debt / Total Capital | 57.26 | 55.19 | 56.97 | 57.2 | 55.57 | |||||
Total Liabilities / Total Assets | 61.59 | 63.34 | 62.11 | 62.81 | 62.65 | |||||
EBIT / Interest Expense | 4.02 | 4.68 | 5.23 | 4.79 | 4.75 | |||||
EBITDA / Interest Expense | 5.85 | 6.47 | 6.84 | 6.31 | 6.28 | |||||
(EBITDA - Capex) / Interest Expense | 4.43 | 5.8 | 5.89 | 5.26 | 5.16 | |||||
Total Debt / EBITDA | 4.24 | 4 | 3.5 | 3.7 | 3.62 | |||||
Net Debt / EBITDA | 4.23 | 3.99 | 3.46 | 3.51 | 3.36 | |||||
Total Debt / (EBITDA - Capex) | 5.59 | 4.46 | 4.06 | 4.43 | 4.4 | |||||
Net Debt / (EBITDA - Capex) | 5.59 | 4.45 | 4.01 | 4.21 | 4.09 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -2.81 | 14.12 | 14.74 | -4.09 | 4.21 | |||||
Gross Profit, 1 Yr. Growth % | 3.77 | 4.67 | 11.73 | -1.5 | 5.05 | |||||
EBITDA, 1 Yr. Growth % | 3.82 | 5.8 | 13.3 | -2.68 | 4.64 | |||||
EBITA, 1 Yr. Growth % | 0.78 | 10.28 | 18.75 | -2.92 | 4.34 | |||||
EBIT, 1 Yr. Growth % | 1.55 | 10.87 | 19.45 | -3.04 | 4.33 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -146.99 | -552.98 | 27.83 | -0.3 | 9.86 | |||||
Net Income, 1 Yr. Growth % | -150.21 | -527.36 | 28.18 | -0.41 | 9.9 | |||||
Normalized Net Income, 1 Yr. Growth % | -43.3 | 109.43 | 26.54 | -0.59 | 9.62 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -180.11 | -456.84 | 31.17 | 1.33 | 10.79 | |||||
Accounts Receivable, 1 Yr. Growth % | -9.55 | 15.13 | 12.39 | 5.61 | -1.15 | |||||
Inventory, 1 Yr. Growth % | 7.27 | 20.34 | 4.23 | 7.43 | 13.21 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -4.33 | -5.6 | -5.75 | 2.05 | -0.52 | |||||
Total Assets, 1 Yr. Growth % | -9.93 | -2.49 | 0.44 | 2.42 | 2.69 | |||||
Tangible Book Value, 1 Yr. Growth % | -28.34 | -23.5 | 23.45 | 24.1 | 30.28 | |||||
Common Equity, 1 Yr. Growth % | -22.8 | -7.9 | 4.45 | 6.46 | 9.01 | |||||
Cash From Operations, 1 Yr. Growth % | 10.75 | 8.63 | 2.2 | 7.53 | 10.17 | |||||
Capital Expenditures, 1 Yr. Growth % | -50.87 | -55.28 | 52.36 | 16.25 | 12.7 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 64.18 | 169.28 | -5.37 | -5.82 | 4.42 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 32.6 | 114.34 | -3.66 | -3.36 | 4.69 | |||||
Dividend Per Share, 1 Yr. Growth % | 2.23 | 1.27 | 6.28 | 9.8 | 11.17 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 12.18 | 5.32 | 14.43 | 4.9 | -0.03 | |||||
Gross Profit, 2 Yr. CAGR % | 18.13 | 4.22 | 8.14 | 4.9 | 1.72 | |||||
EBITDA, 2 Yr. CAGR % | 18.81 | 4.81 | 9.48 | 5 | 0.91 | |||||
EBITA, 2 Yr. CAGR % | 18.48 | 7.92 | 16.7 | 9.2 | 2.06 | |||||
EBIT, 2 Yr. CAGR % | 16.18 | 6.11 | 15.08 | 7.61 | 0.57 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -41.48 | 45.9 | 140.63 | 12.89 | 4.66 | |||||
Net Income, 2 Yr. CAGR % | -39.85 | 46.48 | 134.05 | 12.99 | 4.62 | |||||
Normalized Net Income, 2 Yr. CAGR % | -13.43 | 8.97 | 63.86 | 12.41 | 4.6 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -40.85 | 69.08 | 116.35 | 15.29 | 5.96 | |||||
Accounts Receivable, 2 Yr. CAGR % | -2.21 | 2.05 | 14.05 | 8.95 | 2.17 | |||||
Inventory, 2 Yr. CAGR % | 9.73 | 13.62 | 11.99 | 5.82 | 10.28 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 0.54 | -4.97 | -5.67 | -1.93 | 0.76 | |||||
Total Assets, 2 Yr. CAGR % | -3.77 | -6.29 | -1.03 | 1.43 | 2.56 | |||||
Tangible Book Value, 2 Yr. CAGR % | -24.38 | -25.96 | -2.82 | 23.78 | 27.15 | |||||
Common Equity, 2 Yr. CAGR % | -16.82 | -15.68 | -1.92 | 5.45 | 7.73 | |||||
Cash From Operations, 2 Yr. CAGR % | 21.33 | 9.69 | 5.36 | 4.83 | 8.84 | |||||
Capital Expenditures, 2 Yr. CAGR % | -25.14 | -53.13 | -17.46 | 33.09 | 14.46 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 350.92 | 110.82 | 60.47 | -5.6 | -0.84 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 101.47 | 68.72 | 44.18 | -3.51 | 0.59 | |||||
Dividend Per Share, 2 Yr. CAGR % | 4.26 | 1.75 | 3.75 | 8.03 | 10.48 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 30.93 | 12.83 | 8.37 | 7.89 | 4.67 | |||||
Gross Profit, 3 Yr. CAGR % | 35.73 | 13.46 | 6.66 | 4.82 | 4.95 | |||||
EBITDA, 3 Yr. CAGR % | 38.06 | 14.3 | 7.56 | 5.27 | 4.88 | |||||
EBITA, 3 Yr. CAGR % | 44.85 | 15.68 | 11.41 | 9.76 | 7.56 | |||||
EBIT, 3 Yr. CAGR % | 42.97 | 14.38 | 10.38 | 8.69 | 6.51 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -6.33 | 15.76 | 39.61 | 79.39 | 11.87 | |||||
Net Income, 3 Yr. CAGR % | 12.04 | 15.64 | 40.11 | 76.04 | 11.95 | |||||
Normalized Net Income, 3 Yr. CAGR % | 61.83 | 16.22 | 14.37 | 38.81 | 11.56 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -8.91 | 7.68 | 55.36 | 68.02 | 13.77 | |||||
Accounts Receivable, 3 Yr. CAGR % | 36.3 | 3.26 | 5.57 | 11.17 | 5.47 | |||||
Inventory, 3 Yr. CAGR % | 21.99 | 13.16 | 10.4 | 10.45 | 8.23 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 21.31 | -1.55 | -5.23 | -3.17 | -1.46 | |||||
Total Assets, 3 Yr. CAGR % | 23.14 | -3.35 | -4.09 | 0.11 | 1.85 | |||||
Tangible Book Value, 3 Yr. CAGR % | -23 | -24.09 | -12.2 | 5.44 | 25.91 | |||||
Common Equity, 3 Yr. CAGR % | 5.14 | -13.95 | -9.44 | 0.8 | 6.62 | |||||
Cash From Operations, 3 Yr. CAGR % | 33.34 | 16.94 | 7.13 | 6.08 | 6.58 | |||||
Capital Expenditures, 3 Yr. CAGR % | -5.71 | -36.95 | -30.57 | -7.48 | 25.91 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 138.56 | 278.37 | 61.24 | 34.35 | -2.37 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 92.48 | 105.16 | 39.84 | 26.18 | -0.85 | |||||
Dividend Per Share, 3 Yr. CAGR % | 6.18 | 3.25 | 3.24 | 5.73 | 9.06 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 50.6 | 25.62 | 24.06 | 9.59 | 4.93 | |||||
Gross Profit, 5 Yr. CAGR % | 51.88 | 25.54 | 23.94 | 9.96 | 4.66 | |||||
EBITDA, 5 Yr. CAGR % | 54.49 | 27.62 | 25.83 | 10.49 | 4.85 | |||||
EBITA, 5 Yr. CAGR % | 53.55 | 34.09 | 31.82 | 12.28 | 6.97 | |||||
EBIT, 5 Yr. CAGR % | 52.35 | 33.19 | 31.08 | 11.63 | 6.35 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 15.59 | 48.29 | 36.61 | 14.61 | 24.41 | |||||
Net Income, 5 Yr. CAGR % | 21.23 | 66.43 | 50.43 | 14.57 | 24.66 | |||||
Normalized Net Income, 5 Yr. CAGR % | 39.99 | 66.73 | 62.07 | 14.52 | 10.36 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -4.53 | 295.4 | 28.75 | 10.66 | 33.31 | |||||
Accounts Receivable, 5 Yr. CAGR % | 22.04 | 19.33 | 26.92 | 5.61 | 4.2 | |||||
Inventory, 5 Yr. CAGR % | 18.27 | 20.89 | 17.89 | 10.16 | 10.35 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 16.83 | 12.48 | 9.7 | -1.7 | -2.88 | |||||
Total Assets, 5 Yr. CAGR % | 17.72 | 15.19 | 12.83 | -1.46 | -1.49 | |||||
Tangible Book Value, 5 Yr. CAGR % | -9.37 | -18.06 | -15.49 | -7.69 | 1.82 | |||||
Common Equity, 5 Yr. CAGR % | 6.6 | 2.13 | 2.25 | -6.66 | -2.93 | |||||
Cash From Operations, 5 Yr. CAGR % | 60.31 | 26.92 | 21.35 | 11.94 | 7.81 | |||||
Capital Expenditures, 5 Yr. CAGR % | 28.78 | -16.62 | -10.6 | -14.99 | -15.2 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 62.48 | 69.91 | 102.58 | 117 | 32.75 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 69.07 | 96.54 | 70.89 | 51.64 | 22.57 | |||||
Dividend Per Share, 5 Yr. CAGR % | 8.61 | 6.32 | 5.2 | 5.14 | 6.08 |
- Stock Market
- Equities
- MPLX Stock
- Financials MPLX LP
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















